TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20401289

Group type: EXPERIMENTAL
Intervention: Daflon (micronized purified flavonoid fraction) 500 mg (6 tablets daily for 4 days, followed by 2 tablets for 3 days)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 43
Study: 18270352

Group type: EXPERIMENTAL
Intervention: Experimental strategy (n = 475): target tidal volumes of 6 mL/kg of predicted body weight, plateau pressures not exceeding 40 cm H2O, recruitment maneuvers, and higher positive end‐expiratory pressures.
Number of subjects: 983

Group type: COMPARATOR
Intervention: Control strategy (n = 508): target tidal volumes of 6 mL/kg of predicted body weight, plateau airway pressures not exceeding 30 cm H2O, and conventional levels of positive end‐expiratory pressure.
Number of subjects: 983

Group type: EXPERIMENTAL
Intervention: Experimental strategy (n = 475)
Number of subjects: 983

Group type: COMPARATOR
Intervention: Control strategy (n = 508)
Number of subjects: 983
Study: 15885294

Group type: EXPERIMENTAL
Intervention: 800 IU daily oral vitamin D3
Number of subjects: 5292

Group type: EXPERIMENTAL
Intervention: 1000 mg calcium
Number of subjects: 5292

Group type: EXPERIMENTAL
Intervention: Combination of 800 IU vitamin D3 and 1000 mg calcium
Number of subjects: 5292

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5292
Study: 12641886

Group type: EXPERIMENTAL
Intervention: Videoconferencing
Number of subjects: 145

Group type: COMPARATOR
Intervention: Traditional outpatient clinic visits
Number of subjects: 145
Study: 10974132

Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone (2 mg through a metered-dose inhaler with a spacer)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Oral prednisone (2 mg per kilogram of body weight)
Number of subjects: 100
Study: 8669021

Group type: EXPERIMENTAL
Intervention: Laparoscopic procedures (including antireflux operations)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: State registry program for advanced procedures
Number of subjects: 0
Study: 1505150

Group type: EXPERIMENTAL
Intervention: Sch 37370 (5 mg/kg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 6088019

Group type: EXPERIMENTAL
Intervention: IV 5‐fluorouracil (5‐FU) + Methyl‐CCNU (MeCCNU) + Adriamycin (ADM, doxorubicin)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: IV 5‐FU +/‐ MeCCNU
Number of subjects: 192

Group type: COMPARATOR
Intervention: Adriamycin (ADM)
Number of subjects: 192
Study: 31704530

Group type: EXPERIMENTAL
Intervention: Single-balloon catheter (Foley's catheter)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Double-balloon catheter (Cook cervical ripening balloon)
Number of subjects: 120
Study: 30058829

Group type: EXPERIMENTAL
Intervention: Feedback condition (n = 101)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Treatment as usual (TAU; n = 85)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Not-on-track clients in feedback condition (n = 60)
Number of subjects: 186
Study: 27317703

Group type: EXPERIMENTAL
Intervention: Fibrinogen concentrate (FCH)
Number of subjects: 519

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 519
Study: 26173548

Group type: EXPERIMENTAL
Intervention: Double-scope POEM
Number of subjects: 100

Group type: COMPARATOR
Intervention: Single-scope POEM
Number of subjects: 100
Study: 22719014

Group type: EXPERIMENTAL
Intervention: Algorithm group using point‐of‐care rotational thromboelastometry (ROTEM(®))
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group with coagulation management at clinicians' discretion
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Algorithm group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 20444767

Group type: EXPERIMENTAL
Intervention: Doctor's advice (DA)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Direct referral to a cessation clinic (CC)
Number of subjects: 71
Study: 18767591

Group type: EXPERIMENTAL
Intervention: Tendon‐muscle picking therapy
Number of subjects: 112

Group type: COMPARATOR
Intervention: Electroacupuncture (EA)
Number of subjects: 112
Study: 15811059

Group type: EXPERIMENTAL
Intervention: SRP and metronidazole (M, 400 mg tid) for 10 days (T1)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: SRP, weekly professional supragingival plaque removal for 3 months (PC) and placebo (T2)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: SRP, M and PC (T3)
Number of subjects: 44

Group type: COMPARATOR
Intervention: SRP and placebo (C)
Number of subjects: 44
Study: 12395912

Group type: EXPERIMENTAL
Intervention: Acemetacin 60 mg t.i.d.
Number of subjects: 42

Group type: COMPARATOR
Intervention: Indomethacin 25 mg t.i.d.
Number of subjects: 42
Study: 10768739

Group type: EXPERIMENTAL
Intervention: Motion-sensitized MR-signal
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Motion-compensated MR-signal
Number of subjects: 20
Study: 7560468

Group type: EXPERIMENTAL
Intervention: Nebulized adrenaline (2 mg over 10 min)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Nebulized salbutamol (5 mg over 10 min)
Number of subjects: 22
Study: 2026133

Group type: EXPERIMENTAL
Intervention: Experimental group (n = 26) used the NLS‐1 system with videodisc instructional programs, prompts, commitments, and feedback.
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (n = 23) used the NLS‐1 to enter food purchases only.
Number of subjects: 49
Study: 6853746

Group type: EXPERIMENTAL
Intervention: fenoterol hydrobromide (0.5, 1.25, and 2.5 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: isoproterenol (2.8 mg) with phenylephrine (1.25 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: isoetharine (5 mg) with phenylephrine (1.25 mg)
Number of subjects: 24
Study: 31909470

Group type: EXPERIMENTAL
Intervention: Torasemide
Number of subjects: 40

Group type: COMPARATOR
Intervention: Furosemide
Number of subjects: 40
Study: 30324508

Group type: EXPERIMENTAL
Intervention: 2% lignocaine with 1:80,000 adrenaline and 7.4% sodium bicarbonate
Number of subjects: 50

Group type: COMPARATOR
Intervention: 2% lignocaine with 1:80,000 adrenaline
Number of subjects: 50
Study: 27656953

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) training 3 times a week for 8 weeks
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (non-exercising)
Number of subjects: 25
Study: 25134740

Group type: EXPERIMENTAL
Intervention: UP4FUN intervention
Number of subjects: 1940

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1940
Study: 21928233

Group type: EXPERIMENTAL
Intervention: Bicarbonate treatment group (Bic)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Usual-treatment group (no-Bic)
Number of subjects: 600
Study: 19397672

Group type: EXPERIMENTAL
Intervention: LED treatment with a 590-nm wavelength LED array
Number of subjects: 20
Study: 21040410

Group type: EXPERIMENTAL
Intervention: Telbivudine 600 mg/day for 1 year
Number of subjects: 246

Group type: COMPARATOR
Intervention: Lamivudine 100 mg/day for 1 year
Number of subjects: 246
Study: 16858942

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 58

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 58
Study: 12237663

Group type: EXPERIMENTAL
Intervention: Vitamin C (1000 mg/d) and Vitamin E (400 IU/d) supplementation
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79

Group type: COMPARATOR
Intervention: Women at low risk (no supplements)
Number of subjects: 79
Study: 10522857

Group type: EXPERIMENTAL
Intervention: Gasless laparoscopy
Number of subjects: 17

Group type: COMPARATOR
Intervention: Conventional CO2 laparoscopy
Number of subjects: 17
Study: 7856778

Group type: EXPERIMENTAL
Intervention: Community-level multichannel intervention
Number of subjects: 11

Group type: COMPARATOR
Intervention: Comparison communities (control)
Number of subjects: 11
Study: 1788614

Group type: EXPERIMENTAL
Intervention: Gemfibrozil (900 mg daily)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Phenofibrate (300 mg daily)
Number of subjects: 66
Study: 7194945

Group type: EXPERIMENTAL
Intervention: Evening meal of 15% of total caloric intake (form A)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Evening meal of 40% of total caloric intake (form B)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both forms A and B
Number of subjects: 12
Study: 28000620

Group type: EXPERIMENTAL
Intervention: Aerobic exercise in polluted urban environment (Street)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Aerobic exercise in less polluted environment (Forest)
Number of subjects: 38
Study: 25229779

Group type: EXPERIMENTAL
Intervention: Povidone-iodine topical antiseptic
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Vapocoolant spray (1,1,1,3,3 pentafluoropropane and 1,1,1,2‐tetrafluoroethane)
Number of subjects: 50

Group type: COMPARATOR
Intervention: No antiseptic (Group 1)
Number of subjects: 50
Study: 22051141

Group type: EXPERIMENTAL
Intervention: Acute rhinosinusitis with allergic rhinitis
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Acute rhinosinusitis
Number of subjects: 69
Study: 20144207

Group type: EXPERIMENTAL
Intervention: AZD3778
Number of subjects: 0

Group type: COMPARATOR
Intervention: loratadine (antihistamine)
Number of subjects: 0
Study: 18194848

Group type: EXPERIMENTAL
Intervention: POLI Thr706Ala genotype
Number of subjects: 1089
Study: 15938033

Group type: EXPERIMENTAL
Intervention: Candesartan (16 mg/d)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Amlodipine (10 mg/d)
Number of subjects: 28
Study: 12736473

Group type: EXPERIMENTAL
Intervention: Myocardial ACE activity
Number of subjects: 20
Study: 10230747

Group type: EXPERIMENTAL
Intervention: Sibutramine (10 mg)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159
Study: 8768161

Group type: EXPERIMENTAL
Intervention: Ketorolac 60 mg
Number of subjects: 57

Group type: COMPARATOR
Intervention: Diclofenac 75 mg
Number of subjects: 57
Study: 1751798

Group type: EXPERIMENTAL
Intervention: alpha-IFN therapy alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prednisone priming with IFN therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: IFN therapy alone
Number of subjects: 0
Study: 6109686

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg bd
Number of subjects: 10

Group type: COMPARATOR
Intervention: Cimetidine 200 mg tds and 400 mg at night
Number of subjects: 10
Study: 30872130

Group type: EXPERIMENTAL
Intervention: Folate receptor-positive circulating tumour cells (FR+-CTCs)
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Combination of FR+-CTC count and maximum tumour diameter (MTD)
Number of subjects: 382
Study: 30475845

Group type: EXPERIMENTAL
Intervention: Short-duration DAPT (≤6 months)
Number of subjects: 2216

Group type: COMPARATOR
Intervention: Standard-duration DAPT (≥12 months)
Number of subjects: 2216
Study: 27227460

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) treatment, 3 weekly sessions
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 15
Study: 24857051

Group type: EXPERIMENTAL
Intervention: Laparoscopic Roux-en-Y gastric bypass (LRYGB)
Number of subjects: 29
Study: 22126102

Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI) for illicit drugs (cannabis, cocaine, amphetamine-type stimulants, opioids)
Number of subjects: 731

Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI) for cannabis
Number of subjects: 731

Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI) for stimulants
Number of subjects: 731

Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI) for opioids
Number of subjects: 731

Group type: COMPARATOR
Intervention: Waiting-list control condition
Number of subjects: 731
Study: 20392554

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study: 18397695

Group type: EXPERIMENTAL
Intervention: Test formulation (133.3 mg lopinavir/33.3 mg ritonavir)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Reference product (Kaletra 133.3 mg lopinavir/33.3 mg ritonavir)
Number of subjects: 72
Study: 15647968

Group type: EXPERIMENTAL
Intervention: Lower molecular weight hyaluronan (LMW HA) - Ostenil
Number of subjects: 43

Group type: COMPARATOR
Intervention: Higher molecular weight viscosupplement (hylan G‐F 20, Synvisc)
Number of subjects: 43
Study: 12486779

Group type: COMPARATOR
Intervention: Local exhaust ventilation (LEV) at 0 cfm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Local exhaust ventilation (LEV) at 30 cfm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Local exhaust ventilation (LEV) at 75 cfm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Local exhaust ventilation (LEV) at low ventilation rate (30 cfm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Local exhaust ventilation (LEV) at high ventilation rate (75 cfm)
Number of subjects: 0
Study: 9799980

Group type: EXPERIMENTAL
Intervention: Combined spinal-epidural anesthesia (CSE)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Augmented epidural anesthesia (aEA)
Number of subjects: 45
Study: 7705106

Group type: EXPERIMENTAL
Intervention: Aerosolized heparin inhalation (1,000 U/kg)
Number of subjects: 13
Study: 2677269

Group type: EXPERIMENTAL
Intervention: Empiric care (high-dose antacid therapy: 15-30 ml of high-potency antacid one and three hours after meals and at bedtime)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Traditional care (upper gastrointestinal radiography as part of initial evaluation)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Traditional care
Number of subjects: 101
Study: 921531

Group type: EXPERIMENTAL
Intervention: Lumbar sympathectomy
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control (no sympathectomy)
Number of subjects: 51
Study: 31931275

Group type: EXPERIMENTAL
Intervention: DHA supplementation
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (no DHA supplementation)
Number of subjects: 48
Study: 30657120

Group type: EXPERIMENTAL
Intervention: 1 ml/kg of 0.25% caudal bupivacaine mixed with 2 μg/kg neostigmine (group BN)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 1 ml/kg of 0.25% caudal bupivacaine mixed with 50 mcg/kg midazolam (group BM)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 1 ml/kg of 0.25% caudal bupivacaine mixed with 0.5 mg/kg ketamine (group BK)
Number of subjects: 80

Group type: COMPARATOR
Intervention: 1 ml/kg of 0.25% caudal bupivacaine (group B)
Number of subjects: 80
Study: 29911776

Group type: EXPERIMENTAL
Intervention: Multi-concentration level patch test guided DPCP treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional DPCP treatment
Number of subjects: 20
Study: 26123919

Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg every 6 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single-dose study in men
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bone cycle model
Number of subjects: 0
Study: 23473374

Group type: EXPERIMENTAL
Intervention: 0.5 mg/ml mitomycin C (MMC) applied at the site of discectomy for 5 minutes
Number of subjects: 75

Group type: COMPARATOR
Intervention: Saline applied at the site of discectomy for 5 minutes
Number of subjects: 75
Study: 20456910

Group type: EXPERIMENTAL
Intervention: Constant practice condition (reading aloud sentence stimuli with four Chinese characters)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Blocked practice condition (reading aloud sentence stimuli with increasing sentence length from two to five characters)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Random practice condition (reading sentence stimuli of variable length from two to five characters presented in a random fashion)
Number of subjects: 21
Study: 19594864

Group type: EXPERIMENTAL
Intervention: Probiotic group (L. gasseri CECT5714 and L. coryniformis CECT5711)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (conventional yogurt)
Number of subjects: 44
Study: 17165052

Group type: EXPERIMENTAL
Intervention: Resistance Respiratory Muscle Training (RRMT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Endurance Respiratory Muscle Training (ERMT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo Respiratory Muscle Training (PRMT)
Number of subjects: 30
Study: 15563434

Group type: EXPERIMENTAL
Intervention: 74‐item semi‐quantitative food frequency questionnaire (FFQ)
Number of subjects: 159

Group type: COMPARATOR
Intervention: 3‐day weighed food records (WFR)
Number of subjects: 159
Study: 11176181

Group type: EXPERIMENTAL
Intervention: Optical fiber scope
Number of subjects: 30

Group type: COMPARATOR
Intervention: Chest roentgenogram (CXR)
Number of subjects: 30
Study: 9541091

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 8006243

Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg/day)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 2801589

Group type: EXPERIMENTAL
Intervention: Calcium carbonate supplement (1500 mg Ca/d)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 169
Study: 4425917

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Practolol
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31230343

Group type: EXPERIMENTAL
Intervention: Patients with residual PVOI ≥ 5%
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Age > 65 years
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: PVOI ≥ 25% at PE diagnosis
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Elevated factor VIII
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Chronic respiratory disease
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Patients with ≥ 1 of these factors
Number of subjects: 371
Study: 28376732

Group type: EXPERIMENTAL
Intervention: Pre-pregnancy consumption of vegetables on sandwiches
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: Pre-pregnancy consumption of other vegetables
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: Pre-pregnancy consumption of fruits (apples, pears, oranges or bananas)
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: Pre-pregnancy consumption of other fruits and berries
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: Pre-pregnancy consumption of fruits and vegetables as snacks
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: Daily consumption of vegetables with dinner
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: Older women
Number of subjects: 575
Study: 23048047

Group type: EXPERIMENTAL
Intervention: Positive feedback
Number of subjects: 54

Group type: COMPARATOR
Intervention: Negative feedback
Number of subjects: 54

Group type: COMPARATOR
Intervention: No feedback
Number of subjects: 54
Study: 23647285

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Antidepressant Medications (ADMs)
Number of subjects: 178
Study: 23350342

Group type: EXPERIMENTAL
Intervention: Etidronate and calcitonin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parathyroid hormone (PTH) 1-84
Number of subjects: 0
Study: 19482956

Group type: COMPARATOR
Intervention: Standard oral care with 0.12% chlorhexidine digluconate
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Standard oral care plus electric toothbrushing
Number of subjects: 147
Study: 16998134

Group type: COMPARATOR
Intervention: Conventional approach - caries removed by dental burs, filled with light-cured resin-modified glass ionomer
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: ART approach - caries removed by hand instruments, filled with chemically cured high-strength glass ionomer
Number of subjects: 103
Study: 12441260

Group type: EXPERIMENTAL
Intervention: VAC (vincristine, doxorubicin, cyclophosphamide) and VIAc (vincristine, ifosfamide, actinomycin) chemotherapy regimen
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Surgery, surgery+radiotherapy, or radiotherapy only as local treatment
Number of subjects: 157

Group type: COMPARATOR
Intervention: Previous studies with three-drug VAC regimen (REA-1) and four-drug VACAc regimen (REA-2 and REN-1)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Previous study (REN-2) with a six-drug regimen
Number of subjects: 157
Study: 10515844

Group type: EXPERIMENTAL
Intervention: GM‐CSF plus sodium stibogluconate (20 mg/kg‐1/day‐1 for 20 days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (saline) plus sodium stibogluconate (20 mg/kg‐1/day‐1 for 20 days)
Number of subjects: 20
Study: 7722140

Group type: EXPERIMENTAL
Intervention: Untreated patients with chronic severe anemia
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Red blood cell transfusion in anemic patients
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: NG-mononmethyl-L-arginine (16 mumol/min) in untreated patients
Number of subjects: 14

Group type: COMPARATOR
Intervention: NG-mononmethyl-L-arginine (16 mumol/min) in control subjects
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: NG-mononmethyl-L-arginine (16 mumol/min) in treated patients
Number of subjects: 14
Study: 1723464

Group type: EXPERIMENTAL
Intervention: Nitrendipine (2 x 10 mg daily)
Number of subjects: 28

Group type: COMPARATOR
Intervention: No nitrendipine
Number of subjects: 28
Study: 7347558

Group type: EXPERIMENTAL
Intervention: Amantadine 300 mg/day
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Rimantadine 300 mg/day
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Amantadine 200 mg/day
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Rimantadine 200 mg/day
Number of subjects: 248

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 248
Study: 6746357

Group type: EXPERIMENTAL
Intervention: Radiotherapy (first 10 Gy in five consecutive daily fractions)
Number of subjects: 52
Study: 29287875

Group type: EXPERIMENTAL
Intervention: Coblation
Number of subjects: 101

Group type: COMPARATOR
Intervention: Microdebrider (ME)
Number of subjects: 101
Study: 27930529

Group type: EXPERIMENTAL
Intervention: Propofol (TIVA group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sevoflurane (SEVO group)
Number of subjects: 60
Study: 24584549

Group type: EXPERIMENTAL
Intervention: Sitagliptin (single oral dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21770837

Group type: EXPERIMENTAL
Intervention: Minimal stimulation protocol (5 days CC 100 mg/day then 150 IU uFSH on cycle day 9)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Clomiphene citrate (CC) only
Number of subjects: 113